Where Will Hershey Stock Be In 1 Year?
Chocolate stocks used to be the epitome of sleepy stability,…
Buy
60
CGNX Quote, Financials, Valuation and Earnings
Last price:
$32.50
Seasonality move
:
3.7%
Day range:
$32.02 - $32.81
52-week range:
$22.67 - $53.13
Dividend yield:
0.96%
P/E ratio:
48.21x
P/S ratio:
6.13x
P/B ratio:
3.81x
Volume:
1.2M
Avg. volume:
1.6M
1-year change:
-30.54%
Market cap:
$5.5B
Revenue:
$914.5M
EPS (TTM):
$0.68
Analysts' Opinion
-
Consensus RatingCognex has received a consensus rating of Hold. The company's average rating is a Hold based on 7 Buy ratings, 8 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $37.06, Cognex has an estimated upside of 13.05% from its current price of $32.78.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $27.00 representing 17.63% downside risk from its current price of $32.78.
Fair Value
-
According to the consensus of 16 analysts, Cognex has 13.05% upside to fair value with a price target of $37.06 per share.
CGNX vs. S&P 500
-
Over the past 5 trading days, Cognex has overperformed the S&P 500 by 5.57% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Cognex does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Cognex has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Cognex reported revenues of $216M.
Earnings Growth
-
Cognex has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Cognex reported earnings per share of $0.14.
Enterprise value:
5.3B
EV / Invested capital:
--
Price / LTM sales:
6.13x
EV / EBIT:
41.76x
EV / Revenue:
5.76x
PEG ratio (5yr expected):
2.50x
EV / Free cash flow:
32.64x
Price / Operating cash flow:
34.71x
Enterprise value / EBITDA:
33.25x
Gross Profit (TTM):
$628.2M
Return On Assets:
5.88%
Net Income Margin (TTM):
12.8%
Return On Equity:
7.82%
Return On Invested Capital:
7.82%
Operating Margin:
12.08%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $924.8M | $847.2M | $919.8M | $210.8M | $216M | |
| Gross Profit | $662M | $599.4M | $628.2M | $141.9M | $144.3M | |
| Operating Income | $204.1M | $114.7M | $127M | $14.2M | $26.1M | |
| EBITDA | $223.7M | $139.8M | $159.5M | $22.3M | $34M | |
| Diluted EPS | $1.00 | $0.57 | $0.68 | $0.07 | $0.14 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $625.6M | $672.9M | $722.2M | $661.5M | $577.7M | |
| Total Assets | $1.9B | $1.9B | $2B | $2B | $1.9B | |
| Current Liabilities | $159.7M | $195.1M | $214M | $188.1M | $184M | |
| Total Liabilities | $552M | $575.4M | $527.7M | $524M | $486.9M | |
| Total Equity | $1.4B | $1.4B | $1.4B | $1.5B | $1.4B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $221.4M | $99M | $175.9M | $13.6M | $40.5M | |
| Cash From Investing | -$79.5M | -$11M | $43.1M | -$49M | $33.1M | |
| Cash From Financing | -$141.6M | -$111.4M | -$211.7M | -$25.1M | -$118.4M | |
| Free Cash Flow | $200.9M | $77.4M | $162.5M | $9.6M | $38M | |
CGNX
Sector
Market Cap
$5.5B
$88.7M
Price % of 52-Week High
61.7%
65.02%
Dividend Yield
0.96%
0%
Shareholder Yield
4.23%
0.78%
1-Year Price Total Return
-30.54%
-8.3%
Beta (5-Year)
1.472
0.827
Dividend yield:
0.96%
Annualized payout:
$0.31
Payout ratio:
45%
Growth streak:
3 years
Technicals
8-day SMA
Buy
Level
$31.37
200-day SMA
Sell
Level
$34.67
Bollinger Bands (100)
Buy
Level
26.95 - 33.55
Chaikin Money Flow
Buy
Level
825.4M
20-day SMA
Buy
Level
$30.77
Relative Strength Index (RSI14)
Buy
Level
67.66
ADX Line
Buy
Level
16.78
Williams %R
Sell
Level
-1.7931
50-day SMA
Buy
Level
$29.77
MACD (12, 26)
Buy
Level
0.57
25-day Aroon Oscillator
Buy
Level
24
On Balance Volume
Neutral
Level
558.2M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (8.9821)
Buy
CA Score
(Annual)
Level (1.1364)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-2.2147)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. ID products read codes that have been applied to items during the manufacturing process. Cognex generates the maximum proportion of its sales in the United States and Europe.
Stock Forecast FAQ
In the current month, CGNX has received 7 Buy ratings 8 Hold ratings, and 1 Sell ratings. The CGNX average analyst price target in the past 3 months is $37.06.
-
Where Will Cognex Stock Be In 1 Year?
According to analysts, the consensus estimate is that Cognex share price will rise to $37.06 per share over the next 12 months.
-
What Do Analysts Say About Cognex?
Analysts are divided on their view about Cognex share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cognex is a Sell and believe this share price will drop from its current level to $27.00.
-
What Is Cognex's Price Target?
The price target for Cognex over the next 1-year time period is forecast to be $37.06 according to 16 Wall Street analysts, 7 of them rate the stock a Buy, 1 rates the stock a Sell, and 8 analysts rate the stock a Hold.
-
Is CGNX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Cognex is a Hold. 8 of 16 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of CGNX?
You can purchase shares of Cognex via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cognex shares.
-
What Is The Cognex Share Price Today?
Cognex was last trading at $32.50 per share. This represents the most recent stock quote for Cognex. Yesterday, Cognex closed at $32.78 per share.
-
How To Buy Cognex Stock Online?
In order to purchase Cognex stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will KNOT Stock Be In 1 Year?
In the case of KNOT Offshore Partners (KNOP), most headlines…
Why Is Goldman Sachs Stock Up So Much?
Investment banking giant Goldman Sachs (NYSE:GS) has sharply outperformed the…
Stock Ideas
Buy
63
Is NVDA Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 53x
Buy
60
Is MSFT Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 42x
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
92
BGL alert for Jul 3
Blue Gold [BGL] is down 20.3% over the past day.
Sell
18
CNC alert for Jul 3
Centene [CNC] is down 1.3% over the past day.
Sell
12
MOH alert for Jul 3
Molina Healthcare [MOH] is up 0.3% over the past day.
